International Journal of Drug Policy
Volume 22, Issue 1 , Pages 63-69 , January 2011

Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: Increased risk following diagnosis with hepatitis C infection

  • Scott A. McDonald

      Affiliations

    • Health Protection Scotland, Clifton House, Clifton Place, Glasgow G3 7LN, Scotland, UK
    • Corresponding Author InformationCorresponding author. Fax: +44 141 300 1170.
    • ,
  • Sharon J. Hutchinson

      Affiliations

    • Health Protection Scotland, Clifton House, Clifton Place, Glasgow G3 7LN, Scotland, UK
    • Department of Mathematics and Statistics, University of Strathclyde, 26 Richmond Street, Glasgow G1 1XH, Scotland, UK
    • ,
  • Sheila M. Bird

      Affiliations

    • Department of Mathematics and Statistics, University of Strathclyde, 26 Richmond Street, Glasgow G1 1XH, Scotland, UK
    • MRC Biostatistics Unit, Institute of Public Health, Cambridge CB2 0SR, Scotland, UK
    • ,
  • Chris Robertson

      Affiliations

    • Health Protection Scotland, Clifton House, Clifton Place, Glasgow G3 7LN, Scotland, UK
    • Department of Mathematics and Statistics, University of Strathclyde, 26 Richmond Street, Glasgow G1 1XH, Scotland, UK
    • ,
  • Peter R. Mills

      Affiliations

    • Gartnavel General Hospital, Glasgow G12 0YN, Scotland, UK
    • ,
  • John F. Dillon

      Affiliations

    • Ninewells Hospital & Medical School, Dundee DD 9SY, Scotland, UK
    • ,
  • David J. Goldberg

      Affiliations

    • Health Protection Scotland, Clifton House, Clifton Place, Glasgow G3 7LN, Scotland, UK

Received 3 November 2009 ,Revised 3 April 2010 ,Accepted 20 April 2010.

References 

  1. Andersen PK, Gill RD. Cox's regression model for counting processes: A large sample study. Annals of Statistics. 1982;10:1100–1120
  2. Campbell J, Hagan H, Latka M, Garfein R, Golub E, Coady M, et al. High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend. 2006;81(3):259–265
  3. Carstairs V, Morris R. Deprivation and health in Scotland. Health Bulletin. 1990;48(4):162–175
  4. Freeman A, Law M, Kaldor J, Dore G. Predicting progression to cirrhosis in chronic hepatitis C virus infection. Journal of Viral Hepatitis. 2003;10(4):285–293
  5. Glynn RJ, Buring JE. Ways of measuring rates of recurrent events. British Medical Journal. 1996;312(7027):364–367
  6. Gossop M, Marsden J, Stewart D, Kidd T. The National Treatment Outcome Research Study (NTORS): 4–5 year follow-up results. Addiction. 2003;98(3):291–303
  7. Gossop M, Marsden J, Stewart D, Rolfe A. Patterns of drinking and drinking outcomes among drug misusers. 1-Year follow-up results. Journal of Substance Abuse Treatment. 2000;19(1):45–50
  8. Hagan H, Des Jarlais D. HIV and HCV infection among injecting drug users. Mount Sinai Journal Of Medicine. 2000;67(5–6):423–428
  9. Hutchinson S, Bird S, Goldberg D. Influence of alcohol on the progression of hepatitis C virus infection: A meta-analysis. Clinical Gastroenterology and Hepatology. 2005;3(11):1150–1159
  10. Hutchinson S, Bird S, Goldberg D. Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland. Hepatology. 2005;42(3):711–723
  11. Hutchinson S, Roy K, Wadd S, Bird S, Taylor A, Anderson E, et al. Hepatitis C virus infection in Scotland: Epidemiological review and public health challenges. Scottish Medical Journal. 2006;51(2):8–15
  12. Information Services Division (ISD) . Drug misuse statistics Scotland 2007. Edinburgh: Common Services Agency; 2007;
  13. Kendrick S, Clarke J. The Scottish record linkage system. Health Bulletin (Edinburgh). 1993;51:72–79
  14. Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: An analysis of routine data. Lancet. 2006;367(9504):52–56
  15. McDonald SA, Donaghy M, Goldberg DJ, Hutchinson S, Robertson C, Bird S, et al. A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. Statistical Methods in Medical Research. 2009;18(3):271–283
  16. McDonald SA, Hutchinson S, Bird S, Graham L, Robertson C, Mills P, et al. Association of self-reported alcohol use and hospitalisation for an alcohol-related cause in Scotland: A record-linkage study of 23,183 individuals. Addiction. 2009;104(4):593–602
  17. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. Journal of Viral Hepatitis. 2006;13(1):34–41
  18. Monto A, Patel K, Bostrom A, Pianko S, Pockros P, McHutchison J, et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology. 2004;39(3):826–834
  19. Ostapowicz G, Watson K, Locarnini S, Desmond P. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology. 1998;27(6):1730–1735
  20. R Development Core Team . R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2006;
  21. Roy K, Hay G, Andragetti R, Taylor A, Goldberg D, Wiessing L. Monitoring hepatitis C virus infection among injecting drug users in the European Union: A review of the literature. Epidemiology and Infection. 2002;129(3):577–585
  22. Roy K, Hutchinson S, Wadd S, Taylor A, Cameron S, Burns S, et al. Hepatitis C virus infection among injecting drug users in Scotland: A review of prevalence and incidence data and the methods used to generate them. Epidemiology and Infection. 2007;135(3):433–442
  23. Satagopan J, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach A. A note on competing risks in survival data analysis. British Journal of Cancer. 2004;91(7):1229–1235
  24. Scottish Government Health Department . Hepatitis C action plan for Scotland: Phase II: May 2008–March 2011.. Edinburgh: Scottish Government; 2008;
  25. Scottish Intercollegiate Guidelines Network (SIGN). (2006, December). Management of hepatitis C. A national clinical guideline (SIGN publication; no. 92, 47pp.). Edinburgh: Scottish Intercollegiate Guidelines Network (SIGN).
  26. Shaw L, Taylor A, Roy K, Cameron S, Burns S, Molyneaux P, et al. Establishment of a database of diagnosed HCV-infected persons in Scotland. Commun Dis Public Health. 2003;6(4):305–310
  27. Stein M, Hanna L, Natarajan R, Clarke J, Marisi M, Sobota M, et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. Journal of Substance Abuse Treatment. 2000;18(4):359–363
  28. Taylor A, Allen E, Hutchinson S, Roy K, Goldberg D, Ahmed S, et al. Evaluation of the lord advocate's guidance on the distribution of sterile needles and syringes to injecting drug users. Edinburgh: Scottish Executive (Effective Interventions Unit); 2005;
  29. Twisk J, Smidt N, de Vente W. Applied analysis of recurrent events: A practical overview. Journal of Epidemiology and Community Health. 2005;59(8):706–710
  30. Watson B, Conigrave K, Wallace C, Whitfield J, Wurst F, Haber P. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment. Drug and Alcohol Review. 2007;26(3):231–239
  31. Windeler J, Lange S. Events per person year—A dubious concept. British Medical Journal. 1995;310(6977):454–456

PII: S0955-3959(10)00071-X

doi: 10.1016/j.drugpo.2010.04.003

International Journal of Drug Policy
Volume 22, Issue 1 , Pages 63-69 , January 2011

Article Tools

* Image Usage & Resolution